Calling Justice and Behavioral Health Providers!

Complete the Survey JCOIN is conducting a survey of people who work in corrections and behavioral health to learn more about your thoughts and attitudes around medications for opioid use disorder. If you choose to participate, you will answer survey questions and read a short article about medications for opioid use disorder. Your participation in…

Read More

Budget Impact Tool to Help Estimate Costs of Providing Medications to Treat Opioid Use Disorder in Jails/Prisons

Register for the webinar Despite the evidence that providing medications for opioid use disorder (MOUD; i.e., methadone, buprenorphine, and naltrexone) at the point of incarceration and during reentry reduce the risk of overdose death, decrease recidivism rates, and improve the well-being of the individual, financial and administrative limitations in jail/prison healthcare often serve as barriers…

Read More

HHS Releases New Medicaid Reentry 1115 Demonstration Opportunity to Increase Access to Care for Individuals Leaving Prison and Jail

On April 17, 2023, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), released new guidance that allows states to utilize Medicaid funds to provide health care services to incarcerated individuals, including substance use disorder treatment. The new Medicaid Reentry Section 1115 Demonstration Opportunity would provide states…

Read More

JCOIN Holds In-person Steering Committee Meeting

For the first time since 2019, over 100 researchers and practitioners from the Justice Opioid Innovation Network (JCOIN, NIDA U2CDA050097, PI: Faye Taxman, Ph.D.) gathered in-person to reconnect, celebrate wins, share updates, and further build the community of practice. In addition to members of the JCOIN Steering Committee and the National Institute on Drug Abuse,…

Read More

Study Identifies Key Barriers and Facilitators for Medications to Treat Opioid Use Disorders in U.S. Jails

Download the Fact Sheet (PDF) Findings from JCOINโ€™s Chestnut Health Systems Clinical Research Centerย  Transitioning to the community following incarceration is a particularly high risk for individuals with opioid use disorder (OUD), especially during the first two weeks of release. Substantial evidence shows that initiating medications for opioid use disorder (MOUD) during incarceration and continuation…

Read More

America’s Opioid Ecosystem

Opioids play an outsized role in America’s drug problems, but they also play a critically important role in medicine. Thus, they deserve special attention. Illegally manufactured opioids (such as fentanyl) are involved in a majority of U.S. drug overdoses, but the problems are broader and deeper than drug fatalities. Depending on the drugs involved, there…

Read More

Webinar: Treatment Considerations in the Age of Fentanyl (04-05-23)

Register Now   Wednesday, April 5, 2023 | 12–1:30 p.m. ET Fentanyl and other high potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment. Presenters will discuss practical clinical…

Read More

New Aced It Episode: โ€œPeer Recovery Support Servicesโ€

Season 4, Episode 10: Walking a mile in anotherโ€™s shoes is often a great way to empathize and support someone going through a tough time. However, not all shoes are the same and the miles we walk vary significantly. While peer recovery support is both popular and highly regarded, scholars actually know very little about…

Read More